A team of researchers in China have developed a novel hydrogel combining CBD and fibroblast growth factor 21 (FGF21) to enhance spinal cord injury recovery, according to a study published in Biomaterials. The injectable hydrogel, referred to as C/F/Gel, uses PF127 and α-cyclodextrin (α-CD) to deliver both CBD micelles (CBDm) and FGF21 in a sustained …
Category: News
Aug 07 2025
Study: Psilocybin Therapy Improves Quality of Life in Low-Income Patients With Depression
A new study out of Oregon found that group psilocybin therapy led to significant improvements in quality of life for low-income individuals suffering from depression. The study, first reported by KLCC, involved 19 participants who each took part in two group psilocybin sessions. All participants were in stable housing and receiving therapy, with no personal …
Aug 07 2025
Maine’s Marijuana Sales Hit $23.2 Million in July as Prices Reach New Low
Maine’s adult-use marijuana market generated $23,227,479 in July, the largest monthly total since August 2024, according to new figures released by the Office of Cannabis Policy. The revenue came from 452,395 individual transactions. Through the end of July, licensed marijuana retailers have sold $140,860,230 worth of product, a modest increase over the $137 million collected …
Aug 07 2025
Study: Enhanced CBD Formulations Deliver Up to 5.7 Times Greater Absorption Compared to Standard Capsule
Two newly developed CBD products significantly outperformed a standard isolate capsule in terms of absorption and overall bioavailability, according to a new clinical trial published in the Journal of Cannabis Research. The study compared a bioavailability-enhanced CBD capsule and liquid formulation—both using surfactant/acid technology—to an unformulated CBD isolate capsule in 12 healthy male volunteers. Each …
Aug 07 2025
Study: CBD Reduces Parkinson’s Treatment Side Effect Without Hindering Motor Benefits
A new study finds that cannabidiol (CBD) may offer relief from a common and challenging side effect of Parkinson’s treatment without reducing the therapy’s motor benefits. Published in Progress in Neuro-Psychopharmacology and Biological Psychiatry, the study investigated the effects of CBD and a fluorinated CBD derivative (PECS-101) on L-DOPA-induced dyskinesia (LID)—a frequent complication of prolonged …
Aug 07 2025
13 Minnesota Cities Apply to Open Municipally Run Cannabis Stores
Thirteen cities in Minnesota have applied for licenses to open municipally operated cannabis stores, according to the state’s Office of Cannabis Management (OCM). While most states with legal marijuana have left retail to private businesses, OCM has created a path for cities to take a more active role—mirroring the state’s long-standing model of municipally run …
Aug 06 2025
Rhode Island Marijuana Industry Sets New Sales Record in July
Rhode Island marijuana stores generated $10.48 million in sales in July, setting a new monthly record and bringing the year-to-date total to $68,774,958. The updated figures, released by the Rhode Island Department of Business Regulation, show a steady rise in both adult-use and medical marijuana sales throughout 2025. July’s total marks a significant jump from …
Aug 06 2025
Hawaii Department of Health Announces Free Medical Cannabis CME/CE Courses for Healthcare Providers
The Hawaiʻi Department of Health (DOH) announced today that it is now offering free accredited Continuing Medical Education (CME) and Continuing Education (CE) courses on medical cannabis to licensed healthcare providers in the state. These evidence-based courses are designed to give healthcare providers a foundational understanding of the endocannabinoid system, the largest signaling system in …
Aug 06 2025
Florida Medical Marijuana Sales Total $989 Million in First Seven Months of 2025
Medical marijuana sales in Florida reached nearly $990 million in the first seven months of 2025, according to newly released data from the research firm Headset. Sales peaked in April at $155.47 million, following a steady rise from $145.60 million in January and $139.42 million in February. March brought a jump to $149.70 million before …
Aug 06 2025
Green Thumb Industries Reports $293 Million in Q2 Revenue
Green Thumb Industries brought in $293.3 million in revenue for the second quarter of 2025, marking a 4.7% increase compared to the same period last year. The company ended the quarter with $177 million in cash and $250 million in total debt. Adjusted EBITDA came in at $82.7 million, or 28.2% of revenue, with GAAP …



